FDA Warning Letter — Maryland Specialty And Compounding Pharmacy
The FDA took a Warning Letter action against Maryland Specialty And Compounding Pharmacy on Apr 3, 2017 (Windsor Mill, MD). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Maryland Specialty And Compounding Pharmacy
- Date
- Apr 3, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Windsor Mill, MD (United States)